The Latest Cardiac and Vascular News
PARIS, Jan. 31, 2019 (GLOBE NEWSWIRE) — Quantum Genomics (Euronext Growth – FR0011648971 – ALQGC), a biopharmaceutical company specializing in the development of a new drug class that directly targets the brain to treat resistant hypertension and heart failure, today presents its 2019 corporate action plan. The end of 2018 was marked […]
IRVINE, Calif., Jan. 31, 2019 /PRNewswire/ — Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, today reported financial results for the quarter ended December 31, 2018. Fourth Quarter and Full Year Highlights Q4 sales grew 10.0%; full year 2018 sales grew 8.4%, […]
IRVINE, Calif.–(BUSINESS WIRE)–Endologix, Inc. (Nasdaq: ELGX), a developer and marketer of innovative treatments for aortic disorders, today announced that it will report financial results for the fourth quarter and fiscal year 2018 after the market close on Monday, February 25, 2019. The Company’s management will host a conference call at 4:30 […]
SALT LAKE CITY, Jan. 30, 2019 (GLOBE NEWSWIRE) — XableCath, Inc., announced that its XableCath™ blunt and abrasion tip catheters, were cleared by the FDA as Peripheral Crossing Catheters. The catheters have been safely and successfully used to cross challenging lesions in both arterial CTO’s and chronic obstructive venous lesions. […]
SAN FRANCISCO, Jan. 29, 2019 (GLOBE NEWSWIRE) — iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital healthcare solutions company focused on the advancement of cardiac care, today announced that it will release financial results for the fourth quarter and full year 2018 after the close of trading on Tuesday, February 12, […]
DUBLIN and SAN DIEGO – January 30, 2019 – Medtronic plc (NYSE:MDT) today announced new data supporting the long-term durability, safety, and efficacy of the Valiant(TM) Captivia(TM) thoracic stent graft system for the treatment of blunt thoracic aortic injury (BTAI). The presentation by Himanshu J. Patel, M.D., University of Michigan Department […]
HOLLYWOOD, Fla., Jan. 29, 2019 /PRNewswire/ — The International Symposium on Endovascular Therapy (ISET), today announced that more than 20 highly anticipated research studies, including the first-time presentation of data from a promising clinical research trial, were presented during this year’s meeting, January 27-30 at The Diplomat Hotel in Hollywood, Florida. Below is a summary from […]
VANCOUVER, Jan. 30, 2019 /PRNewswire/ – Neovasc, Inc. (“Neovasc” or the “Company”) (NASDAQ: NVCN)(TSX: NVCN), a leader in the development of minimally invasive transcatheter mitral valve technologies and in the development of minimally invasive devices for the treatment of refractory angina, today announced that the “Institut für das Entgeltsystem im Krankenhaus” (“InEk”), the […]
TORONTO, Jan. 30, 2019 /PRNewswire/ – Baylis Medical is pleased to announce that seasoned marketing executive Gloria Yee has joined Baylis as its Vice President of Marketing. In her role, Gloria will be instrumental in expanding the company’s global commercialization strategy. “We are thrilled to welcome Gloria to Baylis,” said Baylis President Kris Shah. “Her demonstrated […]
BEVERLY HILLS, Calif., Jan. 29, 2019 /PRNewswire/ — Without new treatment options and greater utilization of current cholesterol lowering therapies, the mortality rate from cardiovascular disease (CVD) could increase 62 percent by 2040, according to a study published in the January issue of Clinical Cardiology. While deaths due to CVD have declined over the past 50 years due to improved management […]
